pharmaphorum

JANUARY 5, 2022

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. The post FDA gives AbbVie’s c-Met lung cancer ADC a breakthrough tag appeared first on. Preliminary results from that study showed a 53.8%

Antibody 109

Antibody Drugs Protein Gene 109

pharmaphorum

DECEMBER 23, 2021

Daiichi Sankyo has been granted breakthrough status by the FDA for patritumab deruxtecan, a HER3-targeted antibody-drug conjugate (ADC) in clinical trials for lung cancer. The post FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag appeared first on. Daiichi Sankyo and AZ are close collaborators in the ADC arena.

Drugs 70

Drugs Antibody Clinical Trials Clinical Trials 70

pharmaphorum

APRIL 5, 2022

Immunocore now has approval on both side of the Atlantic for Kimmtrak – the first cancer therapeutic based on T cell receptor (TCR) technology – after getting a green light from the European Commission. Uveal melanoma is a rare cancer of the eye, which in the majority of patients is localised. ” Image by Pexels from Pixabay

Protein 52

Protein Sales Drugs Trials 52

World of DTC Marketing

DECEMBER 13, 2021

OPENING: American cancer patients spent more than $21 billion on their care in 2019. As cancer survival rates rise, so do the price tags of life-saving treatments. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug. What makes cancer such a financial killer?

Drugs 55

Drugs FDA Approval Medicine Containment 55

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. These are particularly important in the progression of certain blood cancers.

Development 52

Development Drugs Clinical Development Antibody 52

pharmaphorum

OCTOBER 29, 2021

Take two recently-approved immunotherapies for triple negative breast cancer (TNBC), put them together, and what do you get? Hopefully a new standard of care for the aggressive disease, according to partners Gilead Sciences and Merck & Co. While its headline revenue of $7.4

Trials 52

Trials Sales FDA Approval Production 52

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. With blood cancers, you inject the product, and the cells are there, and the target is there. We also have the challenge of delivery. Topic sponsors are not involved in the creation of editorial content.

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

pharmaphorum

AUGUST 18, 2022

.” The gene therapy specialist’s chief executive Andrew Obenshain said the approval “marks a watershed moment for the field of gene therapy” and is “ushering in a new era in which gene therapy has the potential to transform existing treatment paradigms for diseases that currently carry a lifelong burden of care.”

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

XTalks

OCTOBER 26, 2021

After initial rejection from the National Institute for Health and Care Excellence (NICE) last year, the non-departmental public body of the Department of Health in England has now given the green light to the gene silencing treatment Givlaari (givosiran) for the treatment of the rare metabolic disorder, acute intermittent porphyria (AIP).

Gene Silencing 98

Gene Silencing Gene Clinical Trials Clinical Trials 98

Delveinsight

FEBRUARY 23, 2021

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. Libtayo for First-line Advanced Non-small Cell Lung Cancer Subset.

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

pharmaphorum

JANUARY 21, 2022

“This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. By 2026, she said, more than half of all public spend on medicines in Europe will be on cancer drugs for just 2% to 3% of the patient base.

Medicine 52

Medicine Marketing Manufacturing Production 52

The Pharma Data

OCTOBER 29, 2021

Merck has tagged to withdraw its Premerger Notification and Report Form, which was originally filed on October 14, 2021, to give the Federal Trade Commission (the “ FTC”) with fresh time for review, and expects to refile similar form on or about November 1, 2021.

Containment 52

Containment Regulation Vaccination Vaccine 52

The Pharma Data

OCTOBER 9, 2021

This designation is predicated on data showing that gantenerumab significantly reduced brain amyloid pillar, a pathological hallmark of Notice, in the ongoing SCarlet RoAD and Marguerite RoAD open- tag extension trials, as well as other studies.

Antibody 52

Antibody In-Vitro Trials Development 52

Rethinking Clinical Trials

MARCH 21, 2023

Goldberg Distinguished Professor and Chief of Oncology Physician-in-Chief, North Carolina Cancer Hospital Director, Cancer Outcomes Research Program University of North Carolina Slides Keywords Patient-reported outcomes, Oncology, Clinical Trials Key Points Symptoms are common in cancer care.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Delveinsight

JULY 22, 2020

Today the tech-based healthcare industry is providing many unique solutions to the patient’s care which are more efficient and effective than the traditional services. Emergency Care. The main priority of hospitals in emergency care is to provide healthcare services in a minimum amount of time. Improved Drug Usage.

Doctors 59

Doctors Doctor Marketing Production 59

XTalks

DECEMBER 21, 2022

Additionally, advanced technologies like artificial intelligence (AI) and the adoption of digital tools in healthcare are allowing for improved treatments and care, and powerful research insights. Some patients may not be familiar with some technologies, which can be a roadblock in virtual care. Gene Therapy Approvals.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

XTalks

JANUARY 19, 2024

Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer.

DNA 66

DNA Radiology FDA Approval Development 66

pharmaphorum

OCTOBER 4, 2022

In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot. Central to the initiative is the aim to gather data from willing participants that can provide greater insights into cancer development and treatment over time. Building a bank.

Biobanking 95

Biobanking Clinical Trials Clinical Trials Trials 95

Delveinsight

DECEMBER 3, 2020

It has been speculated that modifications to the epigenome drive cell ageing, especially a process known as DNA methylation, by which methyl groups are tagged onto DNA. Merck chooses TriNKET cancer immunotherapy program. Merck has snapped up Dragonfly’s TriNKET cancer immunotherapy program.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

Intouch Solutions

JULY 27, 2021

And 17%, or 56 million Americans, can be considered “medically disenfranchised,” with inadequate access to a primary care doctor. The majority of new products coming to market are specialty drugs targeting rare diseases and new breakthrough approaches to cancer treatment – but innovation comes with large price tags.

Drugs 52

Drugs Marketing Vaccination Vaccine 52

pharmaphorum

FEBRUARY 26, 2021

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. Acquisitions post-Janssen. Between 1976 and 1989, James E. billion in cash.

Sales 116

Sales Production Pharma Companies Marketing 116

Drug Discovery World

OCTOBER 21, 2022

The main principle involves a well-defined light source such as that produced by lasers that excites fluorescent tags bound to the cells or particles present in a sample. Careful selection of antibody-fluorophore combination will also minimise spectral overlap and spillover. Kenta Yamamoto received his Ph.D.

Reagent 52

Reagent Antibody Drugs Protein 52

The Pharma Data

MAY 5, 2021

Younger people filling up COVID-19 intensive care wards in Americas, PAHO says ( Reuters ). The long wait for Cel-Sci to finally admit its cancer drug doesn’t work ( STAT ). Day One pivots to an IPO for more funding to back its work in pediatric cancer ( Endpoints ). Medtech.

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52

The Pharma Data

MAY 4, 2021

up 28%, primarily driven by continued strong demand in the metastatic and non-metastatic castration-resistant prostate cancer indications, as well as the metastatic castration-sensitive prostate cancer indication, which was approved in the U.S. in December 2019; and. View source version on businesswire.com : [link]. Source: Pfizer Inc.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharma Marketing Network

JUNE 8, 2020

Unfortunately, having had ten friends my age or younger die by the time I was 40 gave me a very unique look into health care and some of the devastating impacts of it. We are now in a 20-yearlong economic depression for the working and middle class as a result of health care prices inflating, prices not cost.

HR 40

HR Marketing Doctors Doctor 40